SlideShare ist ein Scribd-Unternehmen logo
1 von 9
Downloaden Sie, um offline zu lesen
Continuous Glucose Monitoring Market (CGM Systems,
Application, Diabetic Type, and Adoption by Age Group) -
Current Trends, Size, Share, Industry Analysis, Competitive
Intelligence, Growth, Opportunities and Global Forecasts,
2012 - 2020
Published: Dec 2013
Pages: 92
Contact Us: +1 (617) 674-4143
Toll Free: +1 (855) 711-1555
Mail us: sales@reportsandintelligence.com
Detailed report at:
http://www.reportsandintelligence.com/continuous-glucose-
monitoring-cgm-market
Adoption of CGM- continuous glucose monitoring is a result of innovative diabetic management
devices. Loopholes that exist in the present glucose monitoring devices are efficiently
addressed by the pioneering CGM. With the help of continuous glucose monitoring, noteworthy
progression has been possible to stabilize a high A1C level, which lower downs the risk of
diabetic complications. Few other factors that contribute towards the market growth are
technological modernization such as artificial pancreas, rising awareness among developed,
developing and under developed economies, and rising pool of diabetic patients. Conversely,
factors such as stern authoritarian impositions, lack of reimbursement options, less accurate
results and high cost of the CGMs are impeding the growth of market. The report analyzed the
global continuous glucose monitors market to generate revenue of $568.5 million by 2020,
enrolling a CAGR of 14.8% during 2013-2020. This is due to technological advancements, to be
exact, the launch of artificial pancreas, expediency that the CGMs have over self-monitoring
glucose devices, and earlier detection of the hypo & hyperglycemic events by CGM.
In terms of application, the Global CGM market is divided into diagnostics, home settings, and
hospitals. The home settings segment would be the maximum revenue generator by 2020.
North America generates maximum revenue due to wider adoption of advanced technologies,
effective and well penetrated reimbursement policies, and rising cases of diabetics. Asia Pacific
would grow fastest due to rising pool of patients, per capita income and awareness among the
people.
Top market participants in the market are Medtronics, Animas Corporation, Dexcom, Omnipod
and Miraculins, Inc, Ypsomed AG, inlcuding others. The main tactics adopted by the companies
globally include collaborations, product launches and approvals. Collaborations in the regions
focus on distribution and commercialization of the devices.
KEY BENEFITS
 The report ranks the factors that are responsible to accelerate the market growth driven
by upper hand of CGM over Self monitoring glucose devices, approval for artificial
pancreas and many more
 Market is forecast for the period 2013 - 2020 with market revenues for 2 historic years
of 2010 and 2012
 Identification and analysis of key pockets of investment for CGM manufacturers
 Identification of challenges that must be addressed and overcome in the CGM market to
achieve fiscal success throughout the market
 Analysis of regulatory framework that regulates introduction of new CGM and puts light
on reimbursement scenario
 The report identifies and profiles key market participants that would drive innovation in
the CGM market
KEY MARKET SEGMENTS
GLOBAL MARKET, BY DEVICES
 Transmitter and Receivers
 Sensors
 Insulin Pump
GLOBAL MARKET, BY APPLICATION
 Diagnostics/Clinics
 Hospitals
 Home Settings
GLOBAL MARKET, BY AGE
 Children and Teens
 Youth
 Middle, Elderly and Aged
GLOBAL MARKET, BY GEOGRAPHY
 North America
 Europe
 Asia Pacific
 Row
KEY AUDIENCES
 Medical Devices Manufacturers
 Research Institutions
 Healthcare Institutions
Table of Content
CHAPTER 1 INTRODUCTION
1.1 ObjectivesandScope
1.2 ReportDescription
1.3 KeyBenefitsof the Report
1.4 ResearchMethodology
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 GLOBAL CONTINUOUS GLUCOSEMONITORS MARKET OVERVIEW
3.1 Healthcare ExpenditureonDiabetesWorldwide
3.2 Type-1DiabeticstoRemainKeyTargetfor CGM Market
3.2.1 Type-1Diabetes
3.2.1.1 Type-1DiabetesinYoungPeople
3.2.2 Type-2Diabetes
3.2.2.1 Type-2DiabetesinYoung People
3.2.3 Gestational Diabetes
3.2.4 OtherTypesof Diabetes
3.3 Market Intelligence
3.3.1 Top Factors ImpactingContinuousGlucose MonitorsMarket,2013-2020
3.3.1.1 Fda Approval of Artificial Pancreas
3.3.1.2 Convenience OfferedbyCGMOverSelf MonitoringGlucose Devices
3.3.1.3 Rise inIncidencesof DiabetesCasesGlobally
3.3.1.4 EarlierDetectionof the Hypoand HyperglycemicEventsbyCGM
3.3.1.5 Inadequate ReimbursementOptionsforCGMServe asBarriersfor itsAdoption
3.3.1.6 Accuracy and Cost Actsas a Hindrance inContinuingUse of CGM
3.3.1.7 Strict RegulatoryImpositions
3.3.1.8 Increase inAwarenessAmongDevelopingandUnderdevelopedEconomies
3.3.2 Top Three WinningStrategiesinthe ContinuousGlucose MonitorsMarket
3.3.2.1 Global Market PlayersPositioning
3.3.3 Top InvestmentPocketsinContinuousGlucose MonitorsMarket
3.3.3.1 ContinuousGlucose MonitorsMarket – by Device
3.3.3.2 ContinuousGlucose MonitorsMarket – by Applications
3.3.3.3 ContinuousGlucose MonitorsMarket – by Geography
3.4 Regulations
3.5 ReimbursementScenario
3.6 Market Dynamics
3.6.1 Drivers
3.6.1.1 Convenience OfferedbyCGMOverSelf MonitoringGlucose Devices
3.6.1.2 FDA Approval of Artificial PancreasEnablesClosingthe LoopandOvercomesthe Limitation
of CurrentDiabetesCare ManagementSystem
3.6.1.3 EarlierDetectionof the Hypoand HyperglycemicEventsbyCGM
3.6.1.4 Rise in Incidencesof DiabetesCasesGlobally
3.6.1.5 Increase inAwarenessAmongthe PopulationinDevelopingandUnderdevelopedEconomies
3.6.2 Restraints
3.6.2.1 Strict RegulatoryImpositions
3.6.2.2 Inadequate ReimbursementOptionsforCGMServe asBarriersfor itsAdoption
3.6.2.3 Accuracy and Cost Actsas a Hindrance inContinuingUse of CGM
3.6.3 Market Opportunity
3.6.3.1 Growth inEmergingMarket
3.6.4 WinningStrategiesforMncsin EmergingMarkets
3.6.4.1 Tailoringthe ExistingProductstothe Local Market Needs
3.6.4.2 Adoptionof a Proactive HybridModel RatherThanDistributorManagement
3.6.4.3 Service RenderedMakesaDifference
3.6.4.4 PartnershipandAcquisitionKeytoEnhance Reachand Market Position
3.6.4.5 AdoptingAnEmerging-MarketAttitude
CHAPTER 4 CONTINUOUS GLUCOSEMONITORING SYSTEMS MARKET - BY
DEVICES
4.1 TransmitterandReceivers
4.2 Sensors
4.2.1 Market Trend
4.2.1.1 Non-InvasiveGlucose Sensors
4.2.1.2 SubcutaneousSensors(MinimallyInvasive Sensors)
4.2.1.3 Conventional Technology –Holter-TypeRetrospective Sensors
4.2.1.4 AdvancedTechnology –Real-Time Sensors
4.3 InsulinPump
4.3.1 Advantagesof InsulinPump
4.3.2 Disadvantagesof InsulinPump
4.3.3 Market Trend
CHAPTER 5 CONTINUOUS GLUCOSEMONITORING SYSTEM MARKET - BY
APPLICATION
5.1 Diagnostics/Clinics
5.2 Hospitals
5.3 Home Settings
5.4 Role of CGM in Private Practice
5.4.1 Team Members
5.4.2 Clinical Space
5.4.3 Scheduling
5.4.4 Keepingthe PatientsInformed
CHAPTER 6 CONTINUOUS GLUCOSEMONITORING SYSTEM MARKET – BY AGE
6.1 ChildrenandTeens
6.2 Youth
6.3 Middle ElderlyandAged
CHAPTER 7 CGM SYSTEMS MARKETBY GEOGRAPHY
7.1 NorthAmerica
7.2 Europe
7.2.1 Financial CostIncurred
7.3 AsiaPacific
7.4 Row
CHAPTER 8 COMPANY PROFILES
8.1 MedtronicInc.
8.1.1 CompanyOverview
8.1.2 CompanySnapshot
8.1.3 BusinessPerformance
8.1.4 StrategicMovesand Developments
8.1.4.1 Principal Strategies:ProductLaunch
8.1.4.2 SecondaryStrategies:Approval
8.1.4.3 OtherStrategies:Collaboration
8.1.5 SWOT Analysis&StrategicConclusions
8.2 DexcomInc.
8.2.1 CompanyOverview
8.2.2 CompanySnapshot
8.2.3 BusinessPerformance
8.2.4 StrategicMovesand Developments
8.2.4.1 Principal Strategies:Agreement/Partnership
8.2.4.2 SecondaryStrategies:Acquisition
8.2.5 SWOT Analysis&StrategicConclusions
8.3 NovoNordisk
8.3.1 CompanyProfile
8.3.2 CompanySnapshot
8.3.3 StrategicMovesand Developments
8.3.4 SWOT Analysis&StrategicConclusions
8.4 SpringHealthSolutionLtd
8.4.1 CompanyProfile
8.4.2 CompanySnapshot
8.4.3 StrategicMovesand Developments
8.4.3.1 Principal Strategies
8.4.4 SWOT Analysis&StrategicConclusions
8.5 Roche
8.5.1 CompanyProfile
8.5.2 CompanySnapshot
8.5.3 StrategicMovesand Developments
8.5.4 SWOT Analysis&StrategicConclusions
8.6 AnimasCorporation
8.6.1 CompanyProfile
8.6.2 CompanySnapshot
8.6.3 StrategicMovesand Developments
8.6.3.1 Principal Strategies
8.6.4 SWOT Analysis&StrategicConclusions
8.7 YpsomedAG
8.7.1 CompanyProfile
8.7.2 CompanySnapshot
8.7.3 StrategicMovesand Developments
8.7.3.1 Principal Strategies:ProductExpansion
8.7.3.2 SecondaryStrategies:NewSubsidiary
8.7.3.3 OtherStrategies:AcquisitionandAgreements
8.7.4 SWOT Analysis&StrategicConclusions
8.8 InsuletCorporation
8.8.1 CompanyProfile
8.8.2 CompanySnapshot
8.8.3 StrategicMovesand Developments
8.8.3.1 Principal Strategies
8.8.4 SWOT Analysis&StrategicConclusions
LIST OF TABLES:
TABLE 1 FEATURES OF CURRENTLY AVAILABLESTAND-ALONECGMSYSTEMS (ASOF MARCH 2013)
TABLE 2 FEATURES OF CURRENTLY AVAILABLEINTEGRATEDCGM SYSTEMS (ASOF MARCH 2013)
TABLE 3 GLOBAL CONTINUOUSGLUCOSE MONITORINGSYSTEMS MARKET BY PRODUCT CATEGORY,
2011-2020, ($MILLION)
TABLE 4 GLOBAL CGM TRANSMITTERS ANDRECEIVERSMARKET BY GEOGRAPHY, 2011 - 2020,
($MILLION)
TABLE 5 GLOBAL CGM SENSORSMARKET BY GEOGRAPHY,2011 - 2020, ($MILLION)
TABLE 6 GLOBAL CGM INSULIN PUMP MARKET BY GEOGRAPHY, 2011 - 2020, ($MILLION)
TABLE 7 GLOBAL CGM MARKET BY APPLICATION SEGMENTS,2011 - 2020, ($MILLION)
TABLE 8 GLOBAL CGM MARKET IN DIAGNOSTICCENTERS,BY GEOGRAPHY, 2011 - 2020, ($THOUSAND)
TABLE 9 GLOBAL CGM MARKET IN HOSPITALS,BY GEOGRAPHY,2011 - 2020, ($THOUSAND)
TABLE 10 GLOBAL CGM MARKET IN HOME SETTINGS,BY GEOGRAPHY, 2011 - 2020, ($MILLION)
TABLE 11 GLOBAL CGM MARKET BY AGE, 2011 - 2020, ($MILLION)
TABLE 12 TYPE-1 DIABETES(0-14 YEARS),2013
TABLE 13 FACTORSIMPACTINGGEOGRAPHICAL REGIONSIN 2013 AND 2020
TABLE 14 GLOBAL CONTINUOUSGLUCOSE MONITORINGSYSTEMS BY GEOGRAPHY, 2011 - 2020,
($MILLION)
TABLE 15 THE PREVALENCEOF DIABETESIN THE ADULT POPULATION ACROSSTHE U.K. IN 2011
TABLE 16 PREVALENCEESTIMATES OF DIABETES (20-79 YEARS),2013, EUROPE
TABLE 17 PREVALENCEESTIMATES OF DIABETES,2013 & 2035
TABLE 18 PREVALENCEESTIMATES OF DIABETES (20-79 YEARS),2013, AFRICA REGION
TABLE 19 MEDTRONIC BUSINESS SNAPSHOT
TABLE 20 DEXCOM INC.BUSINESSSNAPSHOT
TABLE 21 NOVA NORDISKBUSINESSSNAPSHOT
TABLE 22 SPRINGHEALTH SOLUTION LTD BUSINESSSNAPSHOT
TABLE 23 ROCHE BUSINESSSNAPSHOT
TABLE 24 ANIMASCORPORATION BUSINESSSNAPSHOT
TABLE 25 YPSOMED AG BUSINESSSNAPSHOT
TABLE 26 INSULET CORPORATION BUSINESSSNAPSHOT
LIST OF FIGURES:
FIG. 1 GLOBAL HEALTH EXPENDITURE DUE TO DIABETES, BY GEOGRAPHY ($BILLION)
FIG. 2 GLOBAL HEALTH EXPENDITURE DUE TO DIABETES,20-79 YEARS ($BILLION)
FIG. 3 TREATMENT OF DIABETES,2011
FIG. 4 SIMILARITIES IN CAUSE OF PRE-DIABETESANDTYPE-2 DIABETES
FIG. 5 CGM ADOPTION BY DIFFERENTTYPES OFDIABETES PATIENTS
FIG. 6 PREVALENCEOF TYPE-1 DIABETES, BY GEOGRAPHY, (THOUSAND)
FIG. 7 GLOBAL PREVALENCEOFTYPE-2 DIABETES IN 2000 & ESTIMATED PREVALENCEIN 2030
FIG. 8 TOP FACTORSIMPACTINGCGM MARKET, 2013-2020
FIG. 9 TOP WINNINGSTRATEGY IN CGMMARKET, 2010 TO 2013 (SEPTEMBER)
FIG. 10 TOP WINNINGSTRATEGY IN CGM MARKET BY YEAR
FIG. 11 GLOBAL MARKET PLAYERS POSITIONING
FIG. 12 TOP INVESTMENTPOCKETSIN CGM DEVICE MARKETS
FIG. 13 TOP INVESTMENTPOCKETSIN CGM APPLICATION MARKETS
FIG. 14 TOP INVESTMENTPOCKETSIN CGM GEOGRAPHY MARKETS
FIG. 15 NUMBER OF INCIDENCESOFDIABETESGLOBALLY, BY GEOGRAPHY (2000, 2011 & 2030)
FIG. 16 GDP PER CAPITA IN EMERGING ECONOMIES
FIG. 17 EMERGING MARKET CAPITALIZATION STRATEGIES
FIG. 18 GLOBAL CGM MARKET AMONG CHILDREN,2011-2020, ($MILLION)
FIG. 19 GLOBAL CGM MARKET AMONG TEENS, 2011-2020, ($MILLION)
FIG. 20 GLOBAL CGM MARKET AMONG YOUTH, 2011-2020, ($MILLION)
FIG. 21 GLOBAL CGM MARKET AMONG MIDDLE ELDERLY, 2011-2020, ($MILLION)
FIG. 22 GLOBAL CGM MARKET AMONG AGED, 2011-2020, ($MILLION)
FIG. 23 NORTH AMERICA CGM MARKET, 2013-2020, ($MILLION)
FIG. 24 CASESOF DIABETES BY AGES IN NAC(1000S) (2013 E)
FIG. 25 EUROPE CGM MARKET, 2013-2020, ($MILLION)
FIG. 26 CASESOF DIABETES BY AGES IN EUROPE (1000S) (2013 E)
FIG. 27 ASIA PACIFICCGMMARKET, 2013-2020, ($MILLION)
FIG. 28 TOP 10 COUNTRIESWITH DIABETESINCIDENCES2013 AND2035
FIG. 29 ROW CGM MARKET, 2013-2020, ($MILLION)
FIG. 30 FINANCIALREVENUESBYBUSINESS UNITS (2013)
FIG. 31 FINANCIALREVENUESBYGEOGRAPHY (2013)
FIG. 32 FINANCIALREVENUES BYGEOGRAPHY (2012)
Contact Us:
Sona Padman
5320 SW MacadamAvenue,
Suite 100, Portland, OR97239
United States
Direct: +1 (617) 674-4143
Toll Free: +1 (855) 711-1555 (U.S. & Canada)
Fax: +1 (855) 550-5975
Email: sales@reportsandintelligence.com
Web: http://www.reportsandintelligence.com/

Weitere ähnliche Inhalte

Kürzlich hochgeladen

blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 

Kürzlich hochgeladen (20)

blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 

Empfohlen

PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024Neil Kimberley
 
Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)contently
 
How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024Albert Qian
 
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsSocial Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsKurio // The Social Media Age(ncy)
 
Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024Search Engine Journal
 
5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summarySpeakerHub
 
ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd Clark Boyd
 
Getting into the tech field. what next
Getting into the tech field. what next Getting into the tech field. what next
Getting into the tech field. what next Tessa Mero
 
Google's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search IntentGoogle's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search IntentLily Ray
 
Time Management & Productivity - Best Practices
Time Management & Productivity -  Best PracticesTime Management & Productivity -  Best Practices
Time Management & Productivity - Best PracticesVit Horky
 
The six step guide to practical project management
The six step guide to practical project managementThe six step guide to practical project management
The six step guide to practical project managementMindGenius
 
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...RachelPearson36
 
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...Applitools
 
12 Ways to Increase Your Influence at Work
12 Ways to Increase Your Influence at Work12 Ways to Increase Your Influence at Work
12 Ways to Increase Your Influence at WorkGetSmarter
 
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...DevGAMM Conference
 

Empfohlen (20)

Skeleton Culture Code
Skeleton Culture CodeSkeleton Culture Code
Skeleton Culture Code
 
PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024
 
Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)
 
How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024
 
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsSocial Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie Insights
 
Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024
 
5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary
 
ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd
 
Getting into the tech field. what next
Getting into the tech field. what next Getting into the tech field. what next
Getting into the tech field. what next
 
Google's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search IntentGoogle's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search Intent
 
How to have difficult conversations
How to have difficult conversations How to have difficult conversations
How to have difficult conversations
 
Introduction to Data Science
Introduction to Data ScienceIntroduction to Data Science
Introduction to Data Science
 
Time Management & Productivity - Best Practices
Time Management & Productivity -  Best PracticesTime Management & Productivity -  Best Practices
Time Management & Productivity - Best Practices
 
The six step guide to practical project management
The six step guide to practical project managementThe six step guide to practical project management
The six step guide to practical project management
 
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
 
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
 
12 Ways to Increase Your Influence at Work
12 Ways to Increase Your Influence at Work12 Ways to Increase Your Influence at Work
12 Ways to Increase Your Influence at Work
 
ChatGPT webinar slides
ChatGPT webinar slidesChatGPT webinar slides
ChatGPT webinar slides
 
More than Just Lines on a Map: Best Practices for U.S Bike Routes
More than Just Lines on a Map: Best Practices for U.S Bike RoutesMore than Just Lines on a Map: Best Practices for U.S Bike Routes
More than Just Lines on a Map: Best Practices for U.S Bike Routes
 
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
 

Continuous Glucose Monitoring Market Reports

  • 1. Continuous Glucose Monitoring Market (CGM Systems, Application, Diabetic Type, and Adoption by Age Group) - Current Trends, Size, Share, Industry Analysis, Competitive Intelligence, Growth, Opportunities and Global Forecasts, 2012 - 2020 Published: Dec 2013 Pages: 92 Contact Us: +1 (617) 674-4143 Toll Free: +1 (855) 711-1555 Mail us: sales@reportsandintelligence.com Detailed report at: http://www.reportsandintelligence.com/continuous-glucose- monitoring-cgm-market
  • 2. Adoption of CGM- continuous glucose monitoring is a result of innovative diabetic management devices. Loopholes that exist in the present glucose monitoring devices are efficiently addressed by the pioneering CGM. With the help of continuous glucose monitoring, noteworthy progression has been possible to stabilize a high A1C level, which lower downs the risk of diabetic complications. Few other factors that contribute towards the market growth are technological modernization such as artificial pancreas, rising awareness among developed, developing and under developed economies, and rising pool of diabetic patients. Conversely, factors such as stern authoritarian impositions, lack of reimbursement options, less accurate results and high cost of the CGMs are impeding the growth of market. The report analyzed the global continuous glucose monitors market to generate revenue of $568.5 million by 2020, enrolling a CAGR of 14.8% during 2013-2020. This is due to technological advancements, to be exact, the launch of artificial pancreas, expediency that the CGMs have over self-monitoring glucose devices, and earlier detection of the hypo & hyperglycemic events by CGM. In terms of application, the Global CGM market is divided into diagnostics, home settings, and hospitals. The home settings segment would be the maximum revenue generator by 2020. North America generates maximum revenue due to wider adoption of advanced technologies, effective and well penetrated reimbursement policies, and rising cases of diabetics. Asia Pacific would grow fastest due to rising pool of patients, per capita income and awareness among the people. Top market participants in the market are Medtronics, Animas Corporation, Dexcom, Omnipod and Miraculins, Inc, Ypsomed AG, inlcuding others. The main tactics adopted by the companies globally include collaborations, product launches and approvals. Collaborations in the regions focus on distribution and commercialization of the devices. KEY BENEFITS  The report ranks the factors that are responsible to accelerate the market growth driven by upper hand of CGM over Self monitoring glucose devices, approval for artificial pancreas and many more  Market is forecast for the period 2013 - 2020 with market revenues for 2 historic years of 2010 and 2012  Identification and analysis of key pockets of investment for CGM manufacturers  Identification of challenges that must be addressed and overcome in the CGM market to achieve fiscal success throughout the market  Analysis of regulatory framework that regulates introduction of new CGM and puts light on reimbursement scenario
  • 3.  The report identifies and profiles key market participants that would drive innovation in the CGM market KEY MARKET SEGMENTS GLOBAL MARKET, BY DEVICES  Transmitter and Receivers  Sensors  Insulin Pump GLOBAL MARKET, BY APPLICATION  Diagnostics/Clinics  Hospitals  Home Settings GLOBAL MARKET, BY AGE  Children and Teens  Youth  Middle, Elderly and Aged GLOBAL MARKET, BY GEOGRAPHY  North America  Europe  Asia Pacific  Row KEY AUDIENCES  Medical Devices Manufacturers  Research Institutions  Healthcare Institutions
  • 4. Table of Content CHAPTER 1 INTRODUCTION 1.1 ObjectivesandScope 1.2 ReportDescription 1.3 KeyBenefitsof the Report 1.4 ResearchMethodology CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 GLOBAL CONTINUOUS GLUCOSEMONITORS MARKET OVERVIEW 3.1 Healthcare ExpenditureonDiabetesWorldwide 3.2 Type-1DiabeticstoRemainKeyTargetfor CGM Market 3.2.1 Type-1Diabetes 3.2.1.1 Type-1DiabetesinYoungPeople 3.2.2 Type-2Diabetes 3.2.2.1 Type-2DiabetesinYoung People 3.2.3 Gestational Diabetes 3.2.4 OtherTypesof Diabetes 3.3 Market Intelligence 3.3.1 Top Factors ImpactingContinuousGlucose MonitorsMarket,2013-2020 3.3.1.1 Fda Approval of Artificial Pancreas 3.3.1.2 Convenience OfferedbyCGMOverSelf MonitoringGlucose Devices 3.3.1.3 Rise inIncidencesof DiabetesCasesGlobally 3.3.1.4 EarlierDetectionof the Hypoand HyperglycemicEventsbyCGM 3.3.1.5 Inadequate ReimbursementOptionsforCGMServe asBarriersfor itsAdoption 3.3.1.6 Accuracy and Cost Actsas a Hindrance inContinuingUse of CGM 3.3.1.7 Strict RegulatoryImpositions 3.3.1.8 Increase inAwarenessAmongDevelopingandUnderdevelopedEconomies 3.3.2 Top Three WinningStrategiesinthe ContinuousGlucose MonitorsMarket 3.3.2.1 Global Market PlayersPositioning 3.3.3 Top InvestmentPocketsinContinuousGlucose MonitorsMarket 3.3.3.1 ContinuousGlucose MonitorsMarket – by Device 3.3.3.2 ContinuousGlucose MonitorsMarket – by Applications 3.3.3.3 ContinuousGlucose MonitorsMarket – by Geography 3.4 Regulations 3.5 ReimbursementScenario 3.6 Market Dynamics 3.6.1 Drivers 3.6.1.1 Convenience OfferedbyCGMOverSelf MonitoringGlucose Devices 3.6.1.2 FDA Approval of Artificial PancreasEnablesClosingthe LoopandOvercomesthe Limitation of CurrentDiabetesCare ManagementSystem 3.6.1.3 EarlierDetectionof the Hypoand HyperglycemicEventsbyCGM
  • 5. 3.6.1.4 Rise in Incidencesof DiabetesCasesGlobally 3.6.1.5 Increase inAwarenessAmongthe PopulationinDevelopingandUnderdevelopedEconomies 3.6.2 Restraints 3.6.2.1 Strict RegulatoryImpositions 3.6.2.2 Inadequate ReimbursementOptionsforCGMServe asBarriersfor itsAdoption 3.6.2.3 Accuracy and Cost Actsas a Hindrance inContinuingUse of CGM 3.6.3 Market Opportunity 3.6.3.1 Growth inEmergingMarket 3.6.4 WinningStrategiesforMncsin EmergingMarkets 3.6.4.1 Tailoringthe ExistingProductstothe Local Market Needs 3.6.4.2 Adoptionof a Proactive HybridModel RatherThanDistributorManagement 3.6.4.3 Service RenderedMakesaDifference 3.6.4.4 PartnershipandAcquisitionKeytoEnhance Reachand Market Position 3.6.4.5 AdoptingAnEmerging-MarketAttitude CHAPTER 4 CONTINUOUS GLUCOSEMONITORING SYSTEMS MARKET - BY DEVICES 4.1 TransmitterandReceivers 4.2 Sensors 4.2.1 Market Trend 4.2.1.1 Non-InvasiveGlucose Sensors 4.2.1.2 SubcutaneousSensors(MinimallyInvasive Sensors) 4.2.1.3 Conventional Technology –Holter-TypeRetrospective Sensors 4.2.1.4 AdvancedTechnology –Real-Time Sensors 4.3 InsulinPump 4.3.1 Advantagesof InsulinPump 4.3.2 Disadvantagesof InsulinPump 4.3.3 Market Trend CHAPTER 5 CONTINUOUS GLUCOSEMONITORING SYSTEM MARKET - BY APPLICATION 5.1 Diagnostics/Clinics 5.2 Hospitals 5.3 Home Settings 5.4 Role of CGM in Private Practice 5.4.1 Team Members 5.4.2 Clinical Space 5.4.3 Scheduling 5.4.4 Keepingthe PatientsInformed CHAPTER 6 CONTINUOUS GLUCOSEMONITORING SYSTEM MARKET – BY AGE 6.1 ChildrenandTeens 6.2 Youth 6.3 Middle ElderlyandAged
  • 6. CHAPTER 7 CGM SYSTEMS MARKETBY GEOGRAPHY 7.1 NorthAmerica 7.2 Europe 7.2.1 Financial CostIncurred 7.3 AsiaPacific 7.4 Row CHAPTER 8 COMPANY PROFILES 8.1 MedtronicInc. 8.1.1 CompanyOverview 8.1.2 CompanySnapshot 8.1.3 BusinessPerformance 8.1.4 StrategicMovesand Developments 8.1.4.1 Principal Strategies:ProductLaunch 8.1.4.2 SecondaryStrategies:Approval 8.1.4.3 OtherStrategies:Collaboration 8.1.5 SWOT Analysis&StrategicConclusions 8.2 DexcomInc. 8.2.1 CompanyOverview 8.2.2 CompanySnapshot 8.2.3 BusinessPerformance 8.2.4 StrategicMovesand Developments 8.2.4.1 Principal Strategies:Agreement/Partnership 8.2.4.2 SecondaryStrategies:Acquisition 8.2.5 SWOT Analysis&StrategicConclusions 8.3 NovoNordisk 8.3.1 CompanyProfile 8.3.2 CompanySnapshot 8.3.3 StrategicMovesand Developments 8.3.4 SWOT Analysis&StrategicConclusions 8.4 SpringHealthSolutionLtd 8.4.1 CompanyProfile 8.4.2 CompanySnapshot 8.4.3 StrategicMovesand Developments 8.4.3.1 Principal Strategies 8.4.4 SWOT Analysis&StrategicConclusions 8.5 Roche 8.5.1 CompanyProfile 8.5.2 CompanySnapshot 8.5.3 StrategicMovesand Developments 8.5.4 SWOT Analysis&StrategicConclusions 8.6 AnimasCorporation 8.6.1 CompanyProfile 8.6.2 CompanySnapshot 8.6.3 StrategicMovesand Developments 8.6.3.1 Principal Strategies
  • 7. 8.6.4 SWOT Analysis&StrategicConclusions 8.7 YpsomedAG 8.7.1 CompanyProfile 8.7.2 CompanySnapshot 8.7.3 StrategicMovesand Developments 8.7.3.1 Principal Strategies:ProductExpansion 8.7.3.2 SecondaryStrategies:NewSubsidiary 8.7.3.3 OtherStrategies:AcquisitionandAgreements 8.7.4 SWOT Analysis&StrategicConclusions 8.8 InsuletCorporation 8.8.1 CompanyProfile 8.8.2 CompanySnapshot 8.8.3 StrategicMovesand Developments 8.8.3.1 Principal Strategies 8.8.4 SWOT Analysis&StrategicConclusions LIST OF TABLES: TABLE 1 FEATURES OF CURRENTLY AVAILABLESTAND-ALONECGMSYSTEMS (ASOF MARCH 2013) TABLE 2 FEATURES OF CURRENTLY AVAILABLEINTEGRATEDCGM SYSTEMS (ASOF MARCH 2013) TABLE 3 GLOBAL CONTINUOUSGLUCOSE MONITORINGSYSTEMS MARKET BY PRODUCT CATEGORY, 2011-2020, ($MILLION) TABLE 4 GLOBAL CGM TRANSMITTERS ANDRECEIVERSMARKET BY GEOGRAPHY, 2011 - 2020, ($MILLION) TABLE 5 GLOBAL CGM SENSORSMARKET BY GEOGRAPHY,2011 - 2020, ($MILLION) TABLE 6 GLOBAL CGM INSULIN PUMP MARKET BY GEOGRAPHY, 2011 - 2020, ($MILLION) TABLE 7 GLOBAL CGM MARKET BY APPLICATION SEGMENTS,2011 - 2020, ($MILLION) TABLE 8 GLOBAL CGM MARKET IN DIAGNOSTICCENTERS,BY GEOGRAPHY, 2011 - 2020, ($THOUSAND) TABLE 9 GLOBAL CGM MARKET IN HOSPITALS,BY GEOGRAPHY,2011 - 2020, ($THOUSAND) TABLE 10 GLOBAL CGM MARKET IN HOME SETTINGS,BY GEOGRAPHY, 2011 - 2020, ($MILLION) TABLE 11 GLOBAL CGM MARKET BY AGE, 2011 - 2020, ($MILLION) TABLE 12 TYPE-1 DIABETES(0-14 YEARS),2013 TABLE 13 FACTORSIMPACTINGGEOGRAPHICAL REGIONSIN 2013 AND 2020 TABLE 14 GLOBAL CONTINUOUSGLUCOSE MONITORINGSYSTEMS BY GEOGRAPHY, 2011 - 2020, ($MILLION) TABLE 15 THE PREVALENCEOF DIABETESIN THE ADULT POPULATION ACROSSTHE U.K. IN 2011 TABLE 16 PREVALENCEESTIMATES OF DIABETES (20-79 YEARS),2013, EUROPE TABLE 17 PREVALENCEESTIMATES OF DIABETES,2013 & 2035 TABLE 18 PREVALENCEESTIMATES OF DIABETES (20-79 YEARS),2013, AFRICA REGION TABLE 19 MEDTRONIC BUSINESS SNAPSHOT TABLE 20 DEXCOM INC.BUSINESSSNAPSHOT TABLE 21 NOVA NORDISKBUSINESSSNAPSHOT TABLE 22 SPRINGHEALTH SOLUTION LTD BUSINESSSNAPSHOT TABLE 23 ROCHE BUSINESSSNAPSHOT TABLE 24 ANIMASCORPORATION BUSINESSSNAPSHOT
  • 8. TABLE 25 YPSOMED AG BUSINESSSNAPSHOT TABLE 26 INSULET CORPORATION BUSINESSSNAPSHOT LIST OF FIGURES: FIG. 1 GLOBAL HEALTH EXPENDITURE DUE TO DIABETES, BY GEOGRAPHY ($BILLION) FIG. 2 GLOBAL HEALTH EXPENDITURE DUE TO DIABETES,20-79 YEARS ($BILLION) FIG. 3 TREATMENT OF DIABETES,2011 FIG. 4 SIMILARITIES IN CAUSE OF PRE-DIABETESANDTYPE-2 DIABETES FIG. 5 CGM ADOPTION BY DIFFERENTTYPES OFDIABETES PATIENTS FIG. 6 PREVALENCEOF TYPE-1 DIABETES, BY GEOGRAPHY, (THOUSAND) FIG. 7 GLOBAL PREVALENCEOFTYPE-2 DIABETES IN 2000 & ESTIMATED PREVALENCEIN 2030 FIG. 8 TOP FACTORSIMPACTINGCGM MARKET, 2013-2020 FIG. 9 TOP WINNINGSTRATEGY IN CGMMARKET, 2010 TO 2013 (SEPTEMBER) FIG. 10 TOP WINNINGSTRATEGY IN CGM MARKET BY YEAR FIG. 11 GLOBAL MARKET PLAYERS POSITIONING FIG. 12 TOP INVESTMENTPOCKETSIN CGM DEVICE MARKETS FIG. 13 TOP INVESTMENTPOCKETSIN CGM APPLICATION MARKETS FIG. 14 TOP INVESTMENTPOCKETSIN CGM GEOGRAPHY MARKETS FIG. 15 NUMBER OF INCIDENCESOFDIABETESGLOBALLY, BY GEOGRAPHY (2000, 2011 & 2030) FIG. 16 GDP PER CAPITA IN EMERGING ECONOMIES FIG. 17 EMERGING MARKET CAPITALIZATION STRATEGIES FIG. 18 GLOBAL CGM MARKET AMONG CHILDREN,2011-2020, ($MILLION) FIG. 19 GLOBAL CGM MARKET AMONG TEENS, 2011-2020, ($MILLION) FIG. 20 GLOBAL CGM MARKET AMONG YOUTH, 2011-2020, ($MILLION) FIG. 21 GLOBAL CGM MARKET AMONG MIDDLE ELDERLY, 2011-2020, ($MILLION) FIG. 22 GLOBAL CGM MARKET AMONG AGED, 2011-2020, ($MILLION) FIG. 23 NORTH AMERICA CGM MARKET, 2013-2020, ($MILLION) FIG. 24 CASESOF DIABETES BY AGES IN NAC(1000S) (2013 E) FIG. 25 EUROPE CGM MARKET, 2013-2020, ($MILLION) FIG. 26 CASESOF DIABETES BY AGES IN EUROPE (1000S) (2013 E) FIG. 27 ASIA PACIFICCGMMARKET, 2013-2020, ($MILLION) FIG. 28 TOP 10 COUNTRIESWITH DIABETESINCIDENCES2013 AND2035 FIG. 29 ROW CGM MARKET, 2013-2020, ($MILLION) FIG. 30 FINANCIALREVENUESBYBUSINESS UNITS (2013) FIG. 31 FINANCIALREVENUESBYGEOGRAPHY (2013) FIG. 32 FINANCIALREVENUES BYGEOGRAPHY (2012)
  • 9. Contact Us: Sona Padman 5320 SW MacadamAvenue, Suite 100, Portland, OR97239 United States Direct: +1 (617) 674-4143 Toll Free: +1 (855) 711-1555 (U.S. & Canada) Fax: +1 (855) 550-5975 Email: sales@reportsandintelligence.com Web: http://www.reportsandintelligence.com/